Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194090 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk
A Phase 4 study of Knee Osteoarthritis, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00194090 is a Phase 4 study of Knee Osteoarthritis that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 40 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00194090, a Phase 4 study of Knee Osteoarthritis, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis
Conditions Studied
Interventions
- DRUG celecoxib
Study Locations (1)
Ohio
- University Hospitals of Cleveland - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194090
The ClinicalTrials.gov registry entry for NCT00194090 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (87% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which celecoxib is the first listed.
NCT00194090 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00194090 about?
NCT00194090 is a clinical study titled "Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk". A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis
What is the current status of trial NCT00194090?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-06. Estimated completion is 2005-09-01.
What conditions does trial NCT00194090 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT00194090?
The interventions under investigation include: celecoxib (DRUG).
Who is sponsoring clinical trial NCT00194090?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194090 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
RECRUITING · Phase 4
-
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
ACTIVE NOT RECRUITING · Phase 4
-
The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis
COMPLETED · Phase 4
-
The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
COMPLETED · Phase 4
-
To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.